Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – Should You Sell?
by Sarita Garza · The Markets DailyOxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $7.93, but opened at $7.34. Oxford BioMedica shares last traded at $7.34, with a volume of 100 shares traded.
Analyst Ratings Changes
Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Check Out Our Latest Research Report on OXBDF
Oxford BioMedica Stock Performance
The stock’s 50-day moving average is $8.02 and its two-hundred day moving average is $8.86.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.